A senior Republican lawmaker said Tuesday he plans to investigate spikes in the price of insulin for people with diabetes as Congress opened hearings on the high cost of prescription drugs.
Jan 29, 2019
0
0
House Democrats announced a sweeping investigation Monday of the pharmaceutical industry's pricing practices, jockeying for the upper hand with the Trump administration on an issue that concerns Americans across the political ...
Jan 14, 2019
0
0
Europeans have found the secret to making some of the world's costliest medicines much more affordable, as much as 80 percent cheaper than in the U.S.
Dec 27, 2018
0
2
(HealthDay)—Acetylsalicylic acid (ASA) hyporesponsiveness after coronary artery bypass graft (CABG) surgery can be overcome by multiple dosing, according to a study published online March 7 in the Journal of Thrombosis ...
Mar 22, 2017
0
0
Developing new drugs is becoming increasingly difficult: research and lab experiments are time consuming and expensive. By making use of data first – screening large databases in order to discover patterns - we can make ...
Mar 9, 2016
1
0
Despite legal and ethical requirements, information on clinical trials for drugs approved by the U.S. Food and Drug Administration (FDA) varied widely among some of the world's largest drug companies, according to a new study ...
Nov 12, 2015
0
36
A research article, published today in Postgraduate Medicine, has concluded that a lack of professional guidance on how to interpret elements of The Physician Payments Sunshine Act (2010) may be having a "chilling effect" ...
Aug 28, 2015
0
4
A promising new natural treatment for Alzheimer's disease is moving toward clinical trials. This will be a major step forward as there is nothing on the market that slows the progression of Alzheimer's.
Mar 11, 2015
1
141
Researchers at the University of Georgia have discovered that a chemical compound commonly found in coffee may help prevent some of the damaging effects of obesity.
Nov 11, 2014
0
0
Children with cancer are being denied new, potentially life-saving drugs, because EU rules are allowing companies to trial some drugs only in adults, leading cancer experts warn today.
Feb 10, 2014
0
0
